Weir S J, Ueda C T
J Pharmacokinet Biopharm. 1986 Dec;14(6):601-13. doi: 10.1007/BF01067966.
Single intravenous bolus doses of amiodarone hydrochloride of 30, 60, 90 and 120 mg/kg were administered to male Sprague-Dawley rats to determine the effects of dose on amiodarone pharmacokinetics. Serial blood samples and total urine were collected over 48 hr and assayed for amiodarone and desethylamiodarone by HPLC. The blood amiodarone concentration-time curves for the four doses were best described by a triexponential equation with terminal half-lives (t1/2 gamma) ranging from 17 to 20 hr. Over the dose range studied, no changes in gamma, t1/2 gamma, or central compartment volume (Vc = 1.2-1.4 L/kg) were observed. On the other hand, reductions in amiodarone clearance (CL) and steady-state volume of distribution (Vss) of 44% (17.7 to 10.0 ml/min per kg) and 50% (16.4 to 8.2 L/kg), respectively, were noted as the dose of amiodarone increased. The conversion of amiodarone to desethylamiodarone (fm) was dose-independent and amounted to approximately 10% of each amiodarone dose. No amiodarone or desethylamiodarone was detected in the urine of any of the treated animals. The blood-to-plasma concentration ratio of amiodarone was concentration-independent and therefore did not account for the dose-dependent changes in Vss and CL observed. The data suggested that the dose-dependent changes noted were due to an alteration in the volume (s) of the peripheral tissue compartment(s).
将30、60、90和120mg/kg的盐酸胺碘酮单次静脉推注剂量给予雄性Sprague-Dawley大鼠,以确定剂量对胺碘酮药代动力学的影响。在48小时内收集系列血样和全部尿液,并用高效液相色谱法测定胺碘酮和去乙基胺碘酮。四个剂量的血胺碘酮浓度-时间曲线用三指数方程能得到最佳描述,其终末半衰期(t1/2γ)范围为17至20小时。在所研究的剂量范围内,未观察到γ、t1/2γ或中央室容积(Vc = 1.2 - 1.4L/kg)的变化。另一方面,随着胺碘酮剂量增加,胺碘酮清除率(CL)和稳态分布容积(Vss)分别降低了44%(从17.7降至10.0ml/min per kg)和50%(从16.4降至8.2L/kg)。胺碘酮向去乙基胺碘酮的转化(fm)与剂量无关,约占每个胺碘酮剂量的10%。在任何处理动物的尿液中均未检测到胺碘酮或去乙基胺碘酮。胺碘酮的血药浓度与血浆浓度之比与浓度无关,因此不能解释所观察到的Vss和CL的剂量依赖性变化。数据表明,所观察到的剂量依赖性变化是由于外周组织室容积的改变所致。